World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
25365
World Ranking
1673
National Ranking
824

Medicine

D-Index
79
Citations
25365
World Ranking
17472
National Ranking
8747

Deborah L. Birx publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Deborah L. Birx sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 241 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Deborah L. Birx D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Deborah L. Birx sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Deborah L. Birx is affiliated with the Centers for Disease Control and Prevention in the United States and has conducted research primarily within the field of Medicine. Their work spans several subfields, including Infectious Diseases, Ecology, Epidemiology, Virology, and Molecular Biology. The research topics covered prominently relate to HIV/AIDS, including research and interventions, drug development and treatment, as well as aspects of genomics and phylogenetic studies. Other notable topics include bacteriophages and microbial interactions and adolescent sexual and reproductive health.

Key recent publications by Deborah L. Birx include:

  • Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey, 2020, The Lancet HIV
  • Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study, 2021, Frontiers in Microbiology
  • The evolution of DREAMS: using data for continuous program improvement, 2022, AIDS
  • Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries, 2022, AIDS
  • Cryo-EM analysis of Pseudomonas phage Pa193 structural components, 2024, Communications Biology

The frequent co-authors associated with their research include Chun-Feng David Hou, A.B. Soriaga, Lucy Sim, Pierre Kyme, and Sébastien Lemire.

Publications by Deborah L. Birx have appeared in various academic venues with multiple contributions in the American Journal of Infection Control, AIDS, and bioRxiv (Cold Spring Harbor Laboratory). Other outlets include The Lancet HIV and Frontiers in Microbiology.

Best Publications

  • Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

    Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal

  • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

    John R. Mascola;Gabriela Stiegler;Thomas C. VanCott;Hermann Katinger

  • Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

    John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris

  • DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells

    Boonrat Tassaneetrithep;Boonrat Tassaneetrithep;Timothy H. Burgess;Angela Granelli-Piperno;Christine Trumpfheller

  • Human skin Langerhans cells are targets of dengue virus infection.

    Shuenn-Jue L. Wu;Geraldine Grouard-Vogel;Wellington Sun;John R. Mascola

  • The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

    N. L. Michael;G. Chang;L. G. Louie;J. R. Mascola

  • Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

    Nathan D. Wolfe;Walid Heneine;Jean K. Carr;Albert D. Garcia

  • Naturally acquired simian retrovirus infections in central African hunters

    Nathan D Wolfe;William M Switzer;Jean K Carr;Vinod B Bhullar

  • Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

    Deborah L. Birx;Robert R. Redfield;Giovanna Tosato

  • A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

    Jeffrey R Currier;Ellen G Kuta;Ellen Turk;Lyndsay B Earhart

  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

    Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  • Effect of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV-1 Infection

    Noah Kiwanuka;Oliver Laeyendecker;Oliver Laeyendecker;Merlin Robb;Godfrey Kigozi

  • Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype Recombinants

    Jean K. Carr;Mika O. Salminen;Jan Albert;Eric Sanders-Buell

  • A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

    Redfield Rr;Birx Dl;Ketter N;Tramont E

  • Induction of interleukin-6 during human immunodeficiency virus infection.

    Deborah L. Birx;Robert R. Redfield;Kathleen Tencer;Arnold Fowler

  • Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand

    Chris Beyrer;Andrew W. Artenstein;Sungwal Rugpao;Henry Stephens

  • CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

    Christof Geldmacher;Jeffrey R. Currier;Eva Herrmann;Antelmo Haule

  • Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

    Bruce L. Levine;Wendy B. Bernstein;Wendy B. Bernstein;Naomi E. Aronson;Naomi E. Aronson;Katia Schlienger

  • Human dendritic cells as targets of dengue virus infection.

    Mary Marovich;Geraldine Grouard-Vogel;Mark Louder;Michael Eller

  • The World Health Organization African Region Laboratory Accreditation Process Improving the Quality of Laboratory Systems in the African Region

    Guy-Michel Gershy-Damet;Philip Rotz;David Cross;El Hadj Belabbes

  • Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America.

    Jean K. Carr;Maria Avila;Manuel Gomez Carrillo;Horacio Salomon

  • Laboratory systems and services are critical in global health: time to end the neglect?

    John N. Nkengasong;Peter Nsubuga;Okey Nwanyanwu;Guy-Michel Gershy-Damet

  • Biologic and Genetic Characterization of a Panel of 60 Human Immunodeficiency Virus Type 1 Isolates, Representing Clades A, B, C, D, CRF01_AE, and CRF02_AG, for the Development and Assessment of Candidate Vaccines

    Bruce K. Brown;Janice M. Darden;Sodsai Tovanabutra;Tamara Oblander

  • Dual Infection with Human Immunodeficiency Virus Type 1 of Distinct Envelope Subtypes in Humans

    Andrew W. Artenstein;Thomas C. VanCott;John R. Mascola;Jean K. Carr

  • Potent and Synergistic Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Hyperimmune Anti-HIV Immunoglobulin Combined with Monoclonal Antibodies 2F5 and 2G12

    J R Mascola;M K Louder;T C VanCott;C V Sapan

  • Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

    N L Michael;G Chang;L A d'Arcy;P K Ehrenberg

  • Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1

    T.C. Vancott;V.R. Polonis;L.D. Loomis;N.L. Michael

Frequent Co-Authors

Francine E. McCutchan
Francine E. McCutchan Columbia University
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Robert R. Redfield
Robert R. Redfield Centers for Disease Control and Prevention
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Donald S. Burke
Donald S. Burke University of Pittsburgh
Josephine H. Cox
Josephine H. Cox National Institute of Allergy and Infectious Diseases
Victoria R. Polonis
Victoria R. Polonis Walter Reed Army Institute of Research
John R. Mascola
John R. Mascola ModeX Therapeutics
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career options in healthcare and research. Many students complement their immunology knowledge with nursing degrees to maximize their impact. For those interested in advancing clinical skills, exploring the fnp to acute care np bridge program can be a vital step, enabling a smooth transition from family nurse practitioner roles to acute care specialties.

For those beginning their nursing journey, the availability of online adn programs for non nurses provides accessible pathways to enter nursing without prior healthcare experience. Accelerated options like the accelerated fnp programs are also popular among students seeking fast-tracked Nurse Practitioner credentials.

Understanding financial prospects is crucial. Resources like the dnp salary by state offer valuable insights into regional earning potentials for Doctor of Nursing Practice graduates, helping students make informed decisions about their education and career trajectory in the immunology-healthcare nexus.

Best Scientists Citing Deborah L. Birx

Trending Scientists

Recently Published Articles